Your browser doesn't support javascript.
loading
Evolution of Head and Neck Cutaneous Squamous Cell Carcinoma Nodal Staging-An Australian Perspective.
Hurrell, Michael J L; Low, Tsu-Hui Hubert; Ebrahimi, Ardalan; Veness, Michael; Ashford, Bruce; Porceddu, Sandro; Clark, Jonathan R.
Afiliação
  • Hurrell MJL; Department of Head and Neck Surgery, Chris O'Brien Lifehouse, Sydney, NSW 2050, Australia.
  • Low TH; Department of Head and Neck Surgery, Chris O'Brien Lifehouse, Sydney, NSW 2050, Australia.
  • Ebrahimi A; Department of Otolaryngology-Head & Neck Surgery, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW 2109, Australia.
  • Veness M; Sydney Medical School, Faculty of Medicine and Health Sciences, University of Sydney, Sydney, NSW 2006, Australia.
  • Ashford B; Medical School, College of Health and Medicine, Australian National University, Canberra, ACT 2601, Australia.
  • Porceddu S; Westmead Hospital, University of Sydney, Westmead, NSW 2006, Australia.
  • Clark JR; School of Medicine, University of Wollongong, Wollongong, NSW 2522, Australia.
Cancers (Basel) ; 14(20)2022 Oct 18.
Article em En | MEDLINE | ID: mdl-36291884
ABSTRACT
Cutaneous squamous cell carcinoma of the head and neck (HNcSCC) is one of the commonest malignancies. When patients present with regional metastatic disease, treatment escalation results in considerable morbidity and survival is markedly reduced. Owing to the high incidence, Australian institutions have been at the forefront of advocating for reliable, accurate, and clinically useful staging systems that recognise the distinct biological characteristics of HNcSCC. As a result, an extensive body of literature has been produced over the past two decades, which has defined critical prognostic factors, critiqued existing staging systems, and proposed alternative staging models. Notwithstanding, a suitable staging system has proved elusive. The goal of cancer staging is to group patients according to cancer characteristics for which survival differs between groups (distinctiveness), consistently decreases with increasing stage (monotonicity), and is similar within a group (homogeneity). Despite implementing major changes based on published data, the latest edition of the American Joint Committee on Cancer (AJCC) staging manual fails to satisfy these fundamental requirements. This review chronologically explores and summarises the Australian contribution to prognostication and nodal staging of HNcSCC and highlights the ongoing challenges.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article